title: FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.
authors.affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, California, USA.
authors.forename: S
authors.initials: S
authors.lastname: Chen
authors.forename: K B
authors.initials: KB
authors.lastname: Bacon
authors.forename: G
authors.initials: G
authors.lastname: Garcia
authors.forename: R
authors.initials: R
authors.lastname: Liao
authors.forename: Z K
authors.initials: ZK
authors.lastname: Pan
authors.forename: S K
authors.initials: SK
authors.lastname: Sullivan
authors.forename: H
authors.initials: H
authors.lastname: Nakano
authors.forename: A
authors.initials: A
authors.lastname: Matsuzawa
authors.forename: V
authors.initials: V
authors.lastname: Brinkmann
authors.forename: L
authors.initials: L
authors.lastname: Feng
mesh_terms: D000818:Animals; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D018925:Chemokines / Q000276:immunology*; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced; D008214:Lymphocytes / Q000187:drug effects / Q000502:physiology*; D008231:Lymphopenia / Q000139:chemically induced; D051379:Mice; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives; D014181:Transplantation Immunology
chemical_list: D018925:Chemokines; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D019869:Phosphatidylinositol 3-Kinases; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine